DarioHealth Corp Ownership

DRIO Stock  USD 0.71  0.01  2.03%   
DarioHealth Corp holds a total of 41.57 Million outstanding shares. DarioHealth Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2012-03-31
Previous Quarter
40.4 M
Current Value
40.4 M
Avarage Shares Outstanding
8.8 M
Quarterly Volatility
12.8 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as DarioHealth Corp in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DarioHealth Corp, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.

DarioHealth Stock Ownership Analysis

About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.39. Some equities with similar Price to Book (P/B) outperform the market in the long run. DarioHealth Corp recorded a loss per share of 0.61. The entity last dividend was issued on the 18th of November 2019. The firm had 1:20 split on the 18th of November 2019. DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Dario Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 200 people. To learn more about DarioHealth Corp call Erez Raphael at 972 477 0637 7 or check out https://www.dariohealth.com.
Besides selling stocks to institutional investors, DarioHealth Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different DarioHealth Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align DarioHealth Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

DarioHealth Corp Quarterly Liabilities And Stockholders Equity

118.88 Million

About 21.0% of DarioHealth Corp are currently held by insiders. Unlike DarioHealth Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against DarioHealth Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of DarioHealth Corp's insider trades

DarioHealth Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as DarioHealth Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DarioHealth Corp backward and forwards among themselves. DarioHealth Corp's institutional investor refers to the entity that pools money to purchase DarioHealth Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Citadel Advisors Llc2024-12-31
71.9 K
Northern Trust Corp2024-12-31
64.6 K
Clarity Capital Partners Llc2024-12-31
28.2 K
Xtx Topco Ltd2024-12-31
24.8 K
The Colony Group Llc2024-12-31
24 K
Susquehanna International Group, Llp2024-12-31
21.8 K
Marco Investment Management Llc2024-12-31
19.2 K
Klingman And Associates, Llc2024-12-31
17.9 K
Pathstone Holdings Llc2024-12-31
15.4 K
Nantahala Capital Management, Llc2024-12-31
2.4 M
Appian Way Asset Management2024-12-31
1.4 M
Note, although DarioHealth Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

DarioHealth Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DarioHealth Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on DarioHealth Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DarioHealth Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Leisure Lawrence B. over three weeks ago
Insider Trading
 
Kaplan Jon H. over three weeks ago
Acquisition by Kaplan Jon H. of 30000 shares of DarioHealth Corp subject to Rule 16b-3
 
Kaplan Jon H. over a month ago
Acquisition by Kaplan Jon H. of tradable shares of DarioHealth Corp at 3.37 subject to Rule 16b-3
 
Stern Adam K over two months ago
Acquisition by Stern Adam K of 100 shares of DarioHealth Corp at 0.83 subject to Rule 16b-3
 
Stern Adam K over two months ago
Acquisition by Stern Adam K of 43850 shares of DarioHealth Corp subject to Rule 16b-3
 
Dror Bacher over two months ago
Acquisition by Dror Bacher of 346 shares of DarioHealth Corp subject to Rule 16b-3
 
Nelson Steven Charles over three months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8045 subject to Rule 16b-3
 
Nelson Steven Charles over three months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.9092 subject to Rule 16b-3
 
Nelson Steven Charles over three months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8045 subject to Rule 16b-3
 
Nelson Steven Charles over three months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8442 subject to Rule 16b-3
 
Nelson Steven Charles over six months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8045 subject to Rule 16b-3
 
Nelson Steven Charles over six months ago
Acquisition by Nelson Steven Charles of 5000 shares of DarioHealth Corp at 0.8 subject to Rule 16b-3

DarioHealth Corp Outstanding Bonds

DarioHealth Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DarioHealth Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DarioHealth bonds can be classified according to their maturity, which is the date when DarioHealth Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pair Trading with DarioHealth Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against DarioHealth Stock

  0.42FNA Paragon 28PairCorr
  0.33GDRX Goodrx HoldingsPairCorr
  0.31MASI MasimoPairCorr
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.61)
Revenue Per Share
0.551
Quarterly Revenue Growth
1.103
Return On Assets
(0.33)
Return On Equity
(0.66)
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.